Fitnesslügen

Literatur

• 1 Baik I, Ascherio A, Rimm E B. et al . Adiposity and mortality in men.  Am J Epidem. 2000;  152 (3) 264-271
• 2 Baynes J W. The Maillard hypothesis on aging: time to focus DNA.  Ann NY Acad Sci. 2002;  959 360-367
• 3 Bender R, Trautner C, Spraul M, Berger M. Assessment of excess mortality in obesity.  Am J Epidem. 1998;  147 42-48
• 4 Brownlee M. The pathobiology of diabetic complications.  Diabetes. 2005;  54 1615-1625
• 5 Calle E E, Thun M J, Petrelli J M. et al . Body-mass index and mortality in a prosective cohort of U.S. adults.  N Engl J Med. 1999;  341 1097-1105
• 6 Chakravarthy M V, Booth F W. Eating, exercise, and “thrifty” genotypes: connecting the dots toward an evolutionary understanding of modern chronic diseases.  J Appl Physiol. 2004;  96 3-10
• 7 Chen Y, Yan S S, Colgan J. et al . Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products.  J Immunol. 2004;  173 1399-1405
• 8 Cipollone F, Iezzi A, Fazia M. et al . The receptor RAGE as a progession factor ampifying arachndonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control.  Circulation. 2003;  108 1070-1077
• 9 Corrada M M, Kawas C H, Mozaffar F, Paganini-Hill A. Association ob body mass index and weight change with all-cause mortality in the elderly.  Am J Epidem. 2006;  163(10) 938-949
• 10 Coutinho M, Gerstein H C, Wang Y, Yusuf S. The relationship between glucose and incidenct cardiovascular events: a metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.  Diabetes Care. 1999;  22 233-240
• 11 De Nigris F, Tajana G, Condorelli M. et al . Glycoxidation of low-denstiy lipoprotein increases TUNEL positivity and CPP32 activation in human coronary cells.  Ann NY Acad Sci. 2003;  1010 710-715
• 12 Dei R, Takeda A, Niwa H. et al . Lipid peroxydation and advanced glycation end products in the brain in normal aging and in Alzheimer's disease.  Acta Neuropathol. 2002;  104 113-122
• 13 Dyer A, Stamler J, Greenland P. Asociations of weight change and weight variability with cardiovascular and all-cause mortality in the Chicago western electric company study.  Am J Epidem. 2000;  152 (4) 324-333
• 14 Flegal K M, Graubard B I, Williamson D F, Gail M H. Excess deaths associated with underweight, overweight, and obesity.  JAMA. 2005;  293 1861-1867
• 15 Friedl K E, Moore R L, Martinez-Lopez L R. et al . Lower limit of body fat in healthy active men.  J Appl Physiol. 1994;  77(2) 933-940
• 16 Goodman M N, Lowell B, Belur E und Ruderman N B. Sites of protein conservation and loss during starvation: influence of adiposity.  Am J Physiol - Endocrinol Metab. 1984;  246 E383-E390
• 17 Haffner S M. The importance of hyperglycemia in the nonfasting state to the development of cardiovacular disease.  Endocr Rev. 1998;  19(5) 583-592
• 18 Hanefeld M, Koehler C, Henkel E. et al . Post-challenge hyperglycaemia relates more strongly than fasting hyperglycaemia with carotid intima-media thickness: the RIAD study.  Diabet Med. 2000;  17 835-840
• 19 Hellerstein M K. De novo lipogenesis in humans: metabolic and regulatory aspects.  Eur J Clin Nutr. 1999;  53 (Suppl. 1) S53-S65
• 20 Hokanson J, Austin M A. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population based on prospective studies.  J Cardiovasc Risk. 1996;  3 213-219
• 21 Hudgins L, Seidman C E, Diakun J, Hirsch J. Human fatty acid synthesis is reduced after the substitution of dietary starch for sugar.  Am J Clin Nutr. 1998;  67 631-639
• 22 Lahmann P H, Lissner L, Gullberg B, Berglund G. A prospective study of adiposity and all-cause mortality: the malmö diet and cancer study.  Obes Res. 2002;  10(5) 361-369
• 23 Lander H L, Tauras J M, Ogiste J S. et al . Activation of the receptor for advanced glycation endproducts triggers a MAP Kinase pathway regulated by oxydative stress.  J Biol Chem. 1997;  272 17810-17814
• 24 Maggi F M, Raselli S, Grigore L. et al . Lipoprotein remnants and endothelial dysfunction in the postprandial phase.  J Clin Endocrinol Metab. 2004;  89 2946-2950
• 25 Mensink G BM. Bundes-Gesundheitssurvey: Körperliche Aktivität. Beiträge zur Gesundheitsberichterstattung des Bundes. Berlin: Robert Koch-Institut; 2003
• 26 Napoli C. Oxidation of LDL, atherogenesis, and apoptosis.  Ann NY Acad Sci. 2003;  1010 698-709
• 27 Nishikawa T, Du Edelstein D XL, Yamagishi S. et al . Normalizing mitochondrial superoxide production blocks three pathways of hyperglycemic damage.  Nature. 2000;  404 787-790
• 28 Obrosova I G. How does glucose generate oxidative stress in periveral nerve?.  Int Rev Neurobiol. 2002;  50 3-35
• 29 Odetti P, Aragno I, Garibaldi S. et al . Role of advanced glycation endproducts in aging collagen. A scanning force microscope study.  Gerontology. 1998;  44 187-191
• 30 Ramasamy R, Vannucci S J, Yan S S. et al . Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation.  Glycobiology. 2005;  15 16R-28R
• 31 Schoen R E, Tangen C M, Kuller L H. et al . Increased blood glucose and insulin, body size, and incident colorectal cancer.  J Nat Canc Inst. 1999;  91(3) 1147-1154
• 32 Schwarz J-M, Linfoot P, Dare D, Aghajanian K. Hepatic de novo lipogenesis in normoinsulinemic and hyperinsulilnemic subjetcs consuming high-fat, low-carbohydrate and low-fat, high-carbohydrate isoenergetic diets.  Am J Clin Nutr. 2003;  77 43-50
• 33 Shoko M, van der Schouw Y T, Gimbrère C HF. et al . Body mass index and short-term weight change in relation to mortality in Dutch women after age 50 y.  Am J Clin Nutr. 2004;  80 231-236
• 34 Steensberg A, van Hall G, Keller C. et al . Muscle glycogen content and glucose uptake during exercise in humans: influence of prios exercise and dietary manipulation.  J Physiol. 2002;  541 273-281
• 35 Tanji N, Markowitz G S, Fu C. et al . The expression of advanged glycation endproducts and their cellular receptor RAGE in diabetic nephropathy and non-diabetic renal disease.  J Am Soc Nephrol. 2000;  11 1656-1666
• 36 Timlin M T, Parks E J. Temporal pattern of de novo lipogenesis in the postprandial state in healthy men.  Am J Clin Nutr. 2005;  81 35-42
• 37 Tominaga M, Eguchi H, Manaka H. et al . Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose.  Diabetes Care. 1999;  22 920-924
• 38 Ulrich P, Cerami A. Protein glycation, diabetes and aging.  Recent Prog Horm Res. 2001;  56 1-21
• 39 U.S. Department of Health and Human Services: Physical Activity and Health .A report of the surgeon general. Atlanta: U.S. Dept. of Health and Human Servs. Centers for Disease Control and Prevention, National Center for Chronic Prevention and Health Promotion; 1996
• 40 Vindis C, Elbaz M, Escargueil-Blanc I. et al . Two distinct calcium-dependent mitochondrial pathways are involved in oxidized LDL-induced Apoptosis.  Arterioscler Thromb Vasc Biol. 2005;  25 639-645
• 41 Wautier M P, Chappey O, Corda S. et al . Activation of NADPH oxidase by advanced glycation endproducts (AGEs) links oxidant stress to altered gen expression via RAGE.  Am J Physiol - Endocrinol Metab. 2001;  280 E685-E694
• 42 Wechsler  (Hrsg.) J G. Adipositas - Ursachen und Therapie. Berlin: Blackwell; 2003. (Kapitel 8-11)
• 43 Weis K M, Buchanan A V. Genetics and the logic of evolution. Hoboken: Wiley; 2004. (Kapitel 2)
• 44 Willett W C, Manson J, Liu S. Glycemic index, glycemic load, and risk of type 2 diabetes.  Am J Clin Nutr. 2002;  76 (Suppl.) 274S-280S
• 45 Yan H, Harding J J. Glycation induced inactivation and loss of antigenicity of catalasse and superoxide dismutase.  Biochem J. 1997;  328 599-605
• 46 Yim M B, Yim H S, Lee C. et al . Protein glycation: creation of catalytic sites for free radical generation.  Ann NY Acad Sci. 2001;  928 48-53

Korrespondenzadresse